Published in
Wiley Open Access, Cancer Science, 7(112), p. 2845-2854, 2021
DOI: 10.1111/cas.14937
Links
Tools
A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma
Journal article published in 2021 by
Yasuhito Terui,
Shinya Rai 
,
Koji Izutsu ,
Motoko Yamaguchi,
Jun Takizawa,
Junya Kuroda,
Takayuki Ishikawa,
Koji Kato ,
Youko Suehiro,
Noriko Fukuhara,
Ken Ohmine,
Hideki Goto,
Kazuhito Yamamoto,
Nobuhiro Kanemura,
Yasunori Ueda
and other authors.
,
Koji Izutsu ,
Motoko Yamaguchi,
Jun Takizawa,
Junya Kuroda,
Takayuki Ishikawa,
Koji Kato ,
Youko Suehiro,
Noriko Fukuhara,
Ken Ohmine,
Hideki Goto,
Kazuhito Yamamoto,
Nobuhiro Kanemura,
Yasunori Ueda
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 